TY - JOUR
T1 - Muscle glycogen synthesis and breakdown are both impaired in glycogenin-1 deficiency
AU - Stemmerik, Mads Godtfeldt
AU - Madsen, Karen Lindhardt
AU - Laforêt, Pascal
AU - Buch, Astrid Emilie
AU - Vissing, John
N1 - © 2017 American Academy of Neurology.
PY - 2017/12/12
Y1 - 2017/12/12
N2 - OBJECTIVE: To study fat and carbohydrate metabolism during exercise in patients with glycogenin-1 (GYG1) deficiency, and to study whether IV glucose supplementation can alleviate exercise intolerance in these patients.METHODS: This is a case-control study with 4 patients with GYG1 deficiency and 4 healthy controls. Patients performed 1 hour of cycling at 50% of their maximal workload capacity, while controls cycled at the same absolute workloads as patients. Heart rate was measured continuously, and production and utilization of fat and glucose was assessed by stable isotope technique. The following day, patients repeated the exercise, this time receiving an IV 10% glucose supplement.RESULTS: Glucose utilization during exercise was similar in patients and controls, while palmitate utilization was greater in patients compared to controls. However, exercise-induced increases in lactate were attenuated to about half normal in patients. This was also the case during a handgrip exercise test. Glucose infusion improved exercise tolerance in patients, and lowered heart rate by on average 11 beats per minute during exercise.CONCLUSIONS: The findings suggest that patients with GYG1 deficiency not only have abnormal formation of glycogen, but also have impaired muscle glycogenolysis, as suggested by impaired lactate production during exercise and improved exercise tolerance with glucose infusion.
AB - OBJECTIVE: To study fat and carbohydrate metabolism during exercise in patients with glycogenin-1 (GYG1) deficiency, and to study whether IV glucose supplementation can alleviate exercise intolerance in these patients.METHODS: This is a case-control study with 4 patients with GYG1 deficiency and 4 healthy controls. Patients performed 1 hour of cycling at 50% of their maximal workload capacity, while controls cycled at the same absolute workloads as patients. Heart rate was measured continuously, and production and utilization of fat and glucose was assessed by stable isotope technique. The following day, patients repeated the exercise, this time receiving an IV 10% glucose supplement.RESULTS: Glucose utilization during exercise was similar in patients and controls, while palmitate utilization was greater in patients compared to controls. However, exercise-induced increases in lactate were attenuated to about half normal in patients. This was also the case during a handgrip exercise test. Glucose infusion improved exercise tolerance in patients, and lowered heart rate by on average 11 beats per minute during exercise.CONCLUSIONS: The findings suggest that patients with GYG1 deficiency not only have abnormal formation of glycogen, but also have impaired muscle glycogenolysis, as suggested by impaired lactate production during exercise and improved exercise tolerance with glucose infusion.
KW - Administration, Intravenous
KW - Adult
KW - Aged
KW - Carbohydrate Metabolism
KW - Case-Control Studies
KW - Exercise
KW - Exercise Tolerance
KW - Female
KW - Glucose/metabolism
KW - Glucosyltransferases/deficiency
KW - Glycogen/biosynthesis
KW - Glycogenolysis
KW - Glycoproteins/deficiency
KW - Heart Rate
KW - Humans
KW - Lactic Acid/metabolism
KW - Lipid Metabolism
KW - Male
KW - Middle Aged
KW - Muscle, Skeletal/metabolism
KW - Palmitates/metabolism
U2 - 10.1212/WNL.0000000000004752
DO - 10.1212/WNL.0000000000004752
M3 - Journal article
C2 - 29142088
SN - 0028-3878
VL - 89
SP - 2491
EP - 2494
JO - Neurology
JF - Neurology
IS - 24
ER -